1 Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nature reviews Cancer 2003; 3: 453-458.
2 Keller L, Pantel K. Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells. Nature reviews Cancer 2019; 19: 553-567.
3 Fidler IJ. The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. European journal of cancer 1973; 9: 223-227.
4 Liotta LA, Saidel MG, Kleinerman J. The significance of hematogenous tumor cell clumps in the metastatic process. Cancer research 1976; 36: 889-894.
5 Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 2014; 158: 1110-1122.
6 Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nature genetics 2008; 40: 1413-1415.
7 Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C et al. Alternative isoform regulation in human tissue transcriptomes. Nature 2008; 456: 470-476.
8 Gruber AJ, Zavolan M. Alternative cleavage and polyadenylation in health and disease. Nature reviews Genetics 2019; 20: 599-614.
9 Chabot B, Shkreta L. Defective control of pre-messenger RNA splicing in human disease. The Journal of cell biology 2016; 212: 13-27.
10 Wang F, Zuroske T, Watts JK. RNA therapeutics on the rise. Nature reviews Drug discovery 2020; 19: 441-442.
11 Khan P, Siddiqui JA, Lakshmanan I, Ganti AK, Salgia R, Jain M et al. RNA-based therapies: A cog in the wheel of lung cancer defense. Molecular cancer 2021; 20: 54.
12 Katzmann JL, Packard CJ, Chapman MJ, Katzmann I, Laufs U. Targeting RNA With Antisense Oligonucleotides and Small Interfering RNA: JACC State-of-the-Art Review. Journal of the American College of Cardiology 2020; 76: 563-579.
13 Kulkarni JA, Witzigmann D, Thomson SB, Chen S, Leavitt BR, Cullis PR et al. The current landscape of nucleic acid therapeutics. Nature nanotechnology 2021; 16: 630-643.
14 Desterro J, Bak-Gordon P, Carmo-Fonseca M. Targeting mRNA processing as an anticancer strategy. Nature reviews Drug discovery 2020; 19: 112-129.
15 Xiong H, Veedu RN, Diermeier SD. Recent Advances in Oligonucleotide Therapeutics in Oncology. International journal of molecular sciences 2021; 22.
16 Szczerba BM, Castro-Giner F, Vetter M, Krol I, Gkountela S, Landin J et al. Neutrophils escort circulating tumour cells to enable cell cycle progression. Nature 2019; 566: 553-557.
17 Gkountela S, Castro-Giner F, Szczerba BM, Vetter M, Landin J, Scherrer R et al. Circulating Tumor Cell Clustering Shapes DNA Methylation to Enable Metastasis Seeding. Cell 2019; 176: 98-112.e114.
18 Jordan NV, Bardia A, Wittner BS, Benes C, Ligorio M, Zheng Y et al. HER2 expression identifies dynamic functional states within circulating breast cancer cells. Nature 2016; 537: 102-106.
19 Donato C, Kunz L, Castro-Giner F, Paasinen-Sohns A, Strittmatter K, Szczerba BM et al. Hypoxia Triggers the Intravasation of Clustered Circulating Tumor Cells. Cell reports 2020; 32: 108105.
20 Picelli S, Björklund Å K, Faridani OR, Sagasser S, Winberg G, Sandberg R. Smart-seq2 for sensitive full-length transcriptome profiling in single cells. Nature methods 2013; 10: 1096-1098.
21 Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics (Oxford, England) 2013; 29: 15-21.
22 Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nature methods 2017; 14: 417-419.
23 Song Y, Botvinnik OB, Lovci MT, Kakaradov B, Liu P, Xu JL et al. Single-Cell Alternative Splicing Analysis with Expedition Reveals Splicing Dynamics during Neuron Differentiation. Molecular cell 2017; 67: 148-161.e145.
24 Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G et al. Integrative genomics viewer. Nature biotechnology 2011; 29: 24-26.
25 Feng X, Li L, Wagner EJ, Li W. TC3A: The Cancer 3' UTR Atlas. Nucleic acids research 2018; 46: D1027-d1030.
26 Li L, Huang KL, Gao Y, Cui Y, Wang G, Elrod ND et al. An atlas of alternative polyadenylation quantitative trait loci contributing to complex trait and disease heritability. Nature genetics 2021; 53: 994-1005.
27 Gao Y, Li L, Amos CI, Li W. Analysis of alternative polyadenylation from single-cell RNA-seq using scDaPars reveals cell subpopulations invisible to gene expression. Genome research 2021.
28 Xiang Y, Ye Y, Lou Y, Yang Y, Cai C, Zhang Z et al. Comprehensive Characterization of Alternative Polyadenylation in Human Cancer. Journal of the National Cancer Institute 2018; 110: 379-389.
29 Piva F, Giulietti M, Burini AB, Principato G. SpliceAid 2: a database of human splicing factors expression data and RNA target motifs. Human mutation 2012; 33: 81-85.
30 Shi Y, Di Giammartino DC, Taylor D, Sarkeshik A, Rice WJ, Yates JR, 3rd et al. Molecular architecture of the human pre-mRNA 3' processing complex. Molecular cell 2009; 33: 365-376.
31 Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome research 2003; 13: 2498-2504.
32 Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics : a journal of integrative biology 2012; 16: 284-287.
33 Punta M, Coggill PC, Eberhardt RY, Mistry J, Tate J, Boursnell C et al. The Pfam protein families database. Nucleic acids research 2012; 40: D290-301.
34 Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. eLife 2015; 4.
35 Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic acids research 2013; 41: D955-961.
36 Rees MG, Seashore-Ludlow B, Cheah JH, Adams DJ, Price EV, Gill S et al. Correlating chemical sensitivity and basal gene expression reveals mechanism of action. Nature chemical biology 2016; 12: 109-116.
37 Satija R, Farrell JA, Gennert D, Schier AF, Regev A. Spatial reconstruction of single-cell gene expression data. Nature biotechnology 2015; 33: 495-502.
38 Tirosh I, Venteicher AS, Hebert C, Escalante LE, Patel AP, Yizhak K et al. Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma. Nature 2016; 539: 309-313.
39 Li S, Hu Z, Zhao Y, Huang S, He X. Transcriptome-Wide Analysis Reveals the Landscape of Aberrant Alternative Splicing Events in Liver Cancer. Hepatology (Baltimore, Md) 2019; 69: 359-375.
40 Wu Q, Zhang Y, An H, Sun W, Wang R, Liu M et al. The landscape and biological relevance of aberrant alternative splicing events in esophageal squamous cell carcinoma. Oncogene 2021; 40: 4184-4197.
41 Lee Y, Rio DC. Mechanisms and Regulation of Alternative Pre-mRNA Splicing. Annual review of biochemistry 2015; 84: 291-323.
42 Cohen-Eliav M, Golan-Gerstl R, Siegfried Z, Andersen CL, Thorsen K, Ørntoft TF et al. The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers. The Journal of pathology 2013; 229: 630-639.
43 Jensen MA, Wilkinson JE, Krainer AR. Splicing factor SRSF6 promotes hyperplasia of sensitized skin. Nature structural & molecular biology 2014; 21: 189-197.
44 Park S, Brugiolo M, Akerman M, Das S, Urbanski L, Geier A et al. Differential Functions of Splicing Factors in Mammary Transformation and Breast Cancer Metastasis. Cell reports 2019; 29: 2672-2688.e2677.
45 Wan L, Yu W, Shen E, Sun W, Liu Y, Kong J et al. SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer. Gut 2019; 68: 118-129.
46 Mayr C, Bartel DP. Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 2009; 138: 673-684.
47 Xia Z, Donehower LA, Cooper TA, Neilson JR, Wheeler DA, Wagner EJ et al. Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3'-UTR landscape across seven tumour types. Nature communications 2014; 5: 5274.
48 Chen M, Lyu G, Han M, Nie H, Shen T, Chen W et al. 3' UTR lengthening as a novel mechanism in regulating cellular senescence. Genome research 2018; 28: 285-294.
49 Müller-McNicoll M, Botti V, de Jesus Domingues AM, Brandl H, Schwich OD, Steiner MC et al. SR proteins are NXF1 adaptors that link alternative RNA processing to mRNA export. Genes & development 2016; 30: 553-566.
50 Schwich OD, Blümel N, Keller M, Wegener M, Setty ST, Brunstein ME et al. SRSF3 and SRSF7 modulate 3'UTR length through suppression or activation of proximal polyadenylation sites and regulation of CFIm levels. Genome biology 2021; 22: 82.
51 Takagaki Y, Seipelt RL, Peterson ML, Manley JL. The polyadenylation factor CstF-64 regulates alternative processing of IgM heavy chain pre-mRNA during B cell differentiation. Cell 1996; 87: 941-952.
52 Masamha CP, Xia Z, Yang J, Albrecht TR, Li M, Shyu AB et al. CFIm25 links alternative polyadenylation to glioblastoma tumour suppression. Nature 2014; 510: 412-416.
53 Chen M, Wan L, Zhang J, Zhang J, Mendez L, Clohessy JG et al. Deregulated PP1α phosphatase activity towards MAPK activation is antagonized by a tumor suppressive failsafe mechanism. Nature communications 2018; 9: 159.
54 Sun H, Ou B, Zhao S, Liu X, Song L, Liu X et al. USP11 promotes growth and metastasis of colorectal cancer via PPP1CA-mediated activation of ERK/MAPK signaling pathway. EBioMedicine 2019; 48: 236-247.
55 Saidy B, Kotecha S, Butler A, Rakha EA, Ellis IO, Green AR et al. PP1, PKA and DARPP-32 in breast cancer: A retrospective assessment of protein and mRNA expression. Journal of cellular and molecular medicine 2021; 25: 5015-5024.
56 Micalizzi DS, Maheswaran S, Haber DA. A conduit to metastasis: circulating tumor cell biology. Genes & development 2017; 31: 1827-1840.
57 Zheng D, Wang R, Ding Q, Wang T, Xie B, Wei L et al. Cellular stress alters 3'UTR landscape through alternative polyadenylation and isoform-specific degradation. Nature communications 2018; 9: 2268.
58 Korthauer KD, Chu LF, Newton MA, Li Y, Thomson J, Stewart R et al. A statistical approach for identifying differential distributions in single-cell RNA-seq experiments. Genome biology 2016; 17: 222.
59 Marinov GK, Williams BA, McCue K, Schroth GP, Gertz J, Myers RM et al. From single-cell to cell-pool transcriptomes: stochasticity in gene expression and RNA splicing. Genome research 2014; 24: 496-510.
60 Westoby J, Herrera MS, Ferguson-Smith AC, Hemberg M. Simulation-based benchmarking of isoform quantification in single-cell RNA-seq. Genome biology 2018; 19: 191.
61 Liu W, Zhang X. Single-cell alternative splicing analysis reveals dominance of single transcript variant. Genomics 2020; 112: 2418-2425.
62 Giuliano M, Shaikh A, Lo HC, Arpino G, De Placido S, Zhang XH et al. Perspective on Circulating Tumor Cell Clusters: Why It Takes a Village to Metastasize. Cancer research 2018; 78: 845-852.
63 Rodrigues P, Vanharanta S. Circulating Tumor Cells: Come Together, Right Now, Over Metastasis. Cancer discovery 2019; 9: 22-24.
64 Falcão AM, van Bruggen D, Marques S, Meijer M, Jäkel S, Agirre E et al. Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis. Nature medicine 2018; 24: 1837-1844.
65 Linker SM, Urban L, Clark SJ, Chhatriwala M, Amatya S, McCarthy DJ et al. Combined single-cell profiling of expression and DNA methylation reveals splicing regulation and heterogeneity. Genome biology 2019; 20: 30.
66 Muñoz JF, Delorey T, Ford CB, Li BY, Thompson DA, Rao RP et al. Coordinated host-pathogen transcriptional dynamics revealed using sorted subpopulations and single macrophages infected with Candida albicans. Nature communications 2019; 10: 1607.